Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies
Apply
ICP-248 & Anti-CD20
Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step